The association of SOX4 as a central mediator of tumor cell survival and chemoresistance by activation of PI3K/AKT and MAPK signaling has been extensively evaluated in B-cell acute lymphoblastic and myeloid leukemias55,56 but this paradigm has not been explored in T-ALL. Here, SOX4 is linked to acute lymphoblastic leukemia.